[HTML][HTML] Molecularly targeted nanomedicine enabled by inorganic nanoparticles for atherosclerosis diagnosis and treatment
Atherosclerosis, a chronic cardiovascular disease caused by plaque development in
arteries, remains a leading cause of morbidity and mortality. Atherosclerotic plaques are …
arteries, remains a leading cause of morbidity and mortality. Atherosclerotic plaques are …
Molecularly targeted nanomedicine enabled by inorganic nanoparticles for atherosclerosis diagnosis and treatment.
X Zhang, F Centurion, A Misra, S Patel… - Advanced Drug Delivery …, 2023 - europepmc.org
Atherosclerosis, a chronic cardiovascular disease caused by plaque development in
arteries, remains a leading cause of morbidity and mortality. Atherosclerotic plaques are …
arteries, remains a leading cause of morbidity and mortality. Atherosclerotic plaques are …
Molecularly targeted nanomedicine enabled by inorganic nanoparticles for atherosclerosis diagnosis and treatment
X Zhang, F Centurion, A Misra… - … drug delivery reviews, 2023 - pubmed.ncbi.nlm.nih.gov
Atherosclerosis, a chronic cardiovascular disease caused by plaque development in
arteries, remains a leading cause of morbidity and mortality. Atherosclerotic plaques are …
arteries, remains a leading cause of morbidity and mortality. Atherosclerotic plaques are …